Can You Donate Blood With Genital Herpes?

The process of blood donation saves countless lives, and maintaining the safety of the blood supply is a primary concern for regulatory and collection organizations. This commitment involves a thorough screening process for every potential donor to ensure the health of both the recipient and the donor. Many individuals with common medical conditions, including viral infections, wonder if their health history prevents them from contributing. The specific health status of the donor at the time of the appointment is the governing factor in determining eligibility.

Eligibility Status for Donors with Herpes

Genital herpes, caused by the Herpes Simplex Virus Type 2 (HSV-2) or sometimes Type 1 (HSV-1), is generally not a permanent disqualifier for blood donation. Major health organizations, including the Food and Drug Administration (FDA) and the American Red Cross, focus on the donor’s current health rather than the history of the infection. A diagnosis of genital herpes, by itself, does not prevent a person from donating blood.

The eligibility rules are designed to distinguish between a chronic, non-symptomatic condition and an acute infection. If the infection is latent, meaning the virus is inactive and the donor is otherwise healthy, they can typically proceed with the donation. This policy reflects an understanding of how the virus functions within the body.

Donors must meet all other general health criteria, such as minimum weight, acceptable hemoglobin levels, and blood pressure readings. The presence of a chronic viral infection does not automatically override these standard requirements, provided the infection is well-managed and asymptomatic. The decision to donate ultimately rests on the donor’s overall state of health on the day of the appointment.

Why Genital Herpes is Not Bloodborne

Genital herpes does not permanently exclude donors because of the unique way the herpes simplex virus establishes itself in the body. Unlike true bloodborne pathogens such as Hepatitis C or HIV, HSV is neurotropic, meaning it primarily infects the nervous system.

After an initial infection, the virus travels along sensory nerves and establishes a lifelong, latent infection within the nerve cell clusters called ganglia. During latency, the virus is dormant and is not found circulating in the bloodstream at levels high enough to be transmissible through a blood transfusion.

Transmission of HSV almost always occurs through direct contact with active lesions, mucosal surfaces, or genital or oral secretions. The virus is not efficiently transferred through the components of donated blood. This biological distinction allows individuals with latent HSV to donate safely without posing a risk to the recipient.

Specific Circumstances That Cause Deferral

While a history of genital herpes is not a disqualification, specific circumstances related to an active infection result in a temporary deferral from donating blood. A primary concern is the presence of an active outbreak, which includes any open sores, blisters, or unhealed lesions, whether oral or genital.

If a potential donor has an active lesion, they will be temporarily deferred until the outbreak has completely resolved. This requires waiting until all sores have fully healed and crusted over, often requiring the donor to be symptom-free for at least 48 hours after healing is complete. During an active outbreak, the virus is multiplying, creating a theoretical, though small, risk of the virus being present in the bloodstream.

Any systemic symptoms that accompany an outbreak, such as a fever, body aches, or swollen lymph nodes, will also lead to a deferral. These symptoms indicate the body is fighting an acute infection, and donation is not advised with any flu-like illness.

Recent use of antiviral medication, such as acyclovir or valacyclovir, taken to treat an acute outbreak, also results in deferral. Donors are asked to wait a certain period after the last dose of the medication before they can donate. This waiting period, often 48 hours or more after finishing the course, ensures the donor is fully recovered and the medication has cleared their system.